Results 281 to 290 of about 76,191 (305)

Time course of organ and hematological response to complement blockage in transplant-associated thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. [PDF]

Front Med (Lausanne)
Rudakova TA, Vlasova JY, Paina OV, Slesarchuk OA, Gorodnova MA, Schegoleva TS, Goloshchapov OV, Bykova TA, Morozova EV, Zubarovskaya LS, Moiseev IS, Kulagin AD.   +11 more
europepmc   +1 more source

Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party. [PDF]

Hemasphere
Bazarbachi A, Labopin M, Dalle IA, Yakoub-Agha I, Socié G, Schroeder T, Blaise D, Poiré X, Balsat M, Salmenniemi U, Kröger N, Kulagin A, Wagner-Drouet EM, Wu D, Brissot E, Nagler A, Giebel S, Ciceri F, Mohty M.   +18 more
europepmc   +1 more source

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation [PDF]

, 1991
Demetris, AJ, Furuya, T, Murase, N, Nalesnik, M, Starzl, TE, Tanabe, M, Todo, S, Woo, J   +7 more
core  

Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect. [PDF]

Bone Marrow Transplant
Koller PB, Othman T, Yang D, Mokhtari S, Samara Y, Blackmon A, Agrawal V, Pourhassan H, Ball BJ, Amanam I, Arslan S, Otoukesh S, Sandhu KS, Aldoss I, Ali H, Salhotra A, Aribi A, Artz A, Becker PS, Pullarkat V, Stewart FM, Smith EP, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM.   +26 more
europepmc   +1 more source

Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis. [PDF]

Sci Rep
Yoshikawa N, Ehara Y, Yamada Y, Matsusaki Y, Shimoda K, Ikeda R.   +5 more
europepmc   +1 more source

Optimization of T-cell-replete haploidentical hematopoietic stem cell transplantation: the Chinese experience. [PDF]

Haematologica
Mo X, Pei X, Huang X.
europepmc   +1 more source

Optimizing Haploidentical Hematopoietic Stem Cell Transplantation: Enhancing Outcomes in Hematologic Malignancies in Resource-Limited Settings. [PDF]

J Blood Med
Owattanapanich W, Karoopongse E, Kittivorapart J, Meeudompong U, Sathapanapitagkit N, Kungwankiattichai S, Vittayawacharin P, Jianthanakanon J, Donsakul N, Bundhit R, Kongsomchit C, Poonmee N, Luangtrakool P, Warindpong T, Chamsai S, Bintaprasit W, Atakulreka S, Kunacheewa C.   +17 more
europepmc   +1 more source

Prevention of chronic GVHD [PDF]

Best Practice & Research Clinical Haematology, 2008
Chronic graft-versus-host disease (GVHD) is the most frequent late complication after hematopoietic-cell transplantation, and it has a major impact on quality of life and survival. As the pathophysiology is still incompletely understood, it has been difficult to design effective prophylactic regimens. However, prevention of acute GVHD appears to result
Jong Wook Lee, H. Joachim Deeg, H. Joachim Deeg   +2 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Separation of GVHD and GVL

Blood, 2010
CD4+Foxp3+ Tregs suppress antitumor responses using a granzyme B–dependent mechanism while the regulatory control of GVHD by Tregs exploits a distinct mechanism that is granzyme B–independent.
openaire   +3 more sources